icon
0%

Henry Schein HSIC - News Analyzed: 5,270 - Last Week: 100 - Last Month: 400

↑ Henry Schein HSIC: Strategic Growth, Acquiering Acentus and Expanding Medical Supplies Portfolio

Henry Schein HSIC: Strategic Growth, Acquiering Acentus and Expanding Medical Supplies Portfolio
Henry Schein (HSIC), the leading provider of healthcare products and services, has been experiencing notable developments. The company's Q4 outlook has been unveiled showcasing Wall Street estimates for its key metrics. A significant strategic investment by KKR has also been announced which includes board changes and preliminary unaudited financial results. The company has also provided financial guidance for 2025. HSIC has been scheduled to participate in several investor conferences and will also be presenting at the J.P. Morgan Healthcare Conference 2025. Furthermore, HSIC stock has been highlighted by numerous analysts, with discussions centered around the company's performance and potential for strategic growth particularly with its recent acquisition of Acentus and the subsequent expansion of its medical equipment portfolio. Amidst these developments, HSIC has also been attention grabbing via its philanthropic efforts, launching a customer emergency support hotline to aid the California wildfires and establishing a relief fund to support the City of Los Angeles. HSIC has also been named to FORTUNE® Magazine’s ‘Change the World’ list.

Henry Schein HSIC News Analytics from Mon, 27 Feb 2023 08:00:00 GMT to Fri, 21 Feb 2025 17:15:19 GMT - Rating 7 - Innovation 4 - Information 8 - Rumor -3

The email address you have entered is invalid.